300502:SZSEEoptolink Technology Inc., Ltd. Class A Analysis
Data as of 2026-03-14 - not real-time
CN¥394.03
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Eoptolink is trading just above its 20‑day SMA (≈381) while still below the 50‑day SMA, with a neutral trend and an RSI hovering around the 50‑mark, suggesting neither strong over‑bought nor over‑sold conditions. Technical momentum appears modestly bullish as the MACD histogram is positive and the MACD signal is flagged bullish, yet the stock faces a sizable support zone near 347 and resistance around 423. Volatility is elevated at roughly 68% over the past 30 days and beta is close to 0.9, indicating market‑aligned price swings. On the fundamentals side, the company posted explosive revenue growth of over 150% YoY, with gross margins near 47% and an extraordinary ROE of about 70%, all while maintaining a very low debt‑to‑equity ratio (~0.11). The dividend payout is minimal (≈0.08% yield) but highly sustainable given the strong cash position and low payout ratio. However, valuation metrics are stretched: the trailing PE sits at 52 versus an industry average of 34, and a discounted cash‑flow model values the stock near 75 CNY, far below the current 394 CNY price. Analyst consensus leans strongly bullish ("strong_buy") with a median target of 481 CNY, highlighting a tension between optimistic earnings expectations and the current over‑valuation.
Overall, while the company’s profitability and growth fundamentals are compelling, the market price appears significantly inflated relative to intrinsic estimates, and heightened volatility coupled with sector‑specific regulatory scrutiny in China adds to the risk profile.
Overall, while the company’s profitability and growth fundamentals are compelling, the market price appears significantly inflated relative to intrinsic estimates, and heightened volatility coupled with sector‑specific regulatory scrutiny in China adds to the risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram signaling short‑term momentum
- Neutral RSI and price near short‑term support
- Elevated volatility and overvalued PE ratio
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high profit margins
- Low leverage and robust operating cash flow
- Forward PE compression as earnings are expected to accelerate
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Current price far exceeds DCF fair value
- Potential regulatory headwinds for Chinese tech firms
- High valuation multiples relative to industry peers
Key Metrics & Analysis
Financial Health
Revenue Growth152.50%
Profit Margin37.55%
P/E Ratio52.1
ROE69.59%
ROA32.93%
Debt/Equity0.11
P/B Ratio26.9
Op. Cash FlowCN¥5.0B
Free Cash FlowCN¥1.9B
Industry P/E33.7
Technical Analysis
TrendNeutral
RSI51.6
SupportCN¥346.74
ResistanceCN¥422.60
MA 20CN¥381.69
MA 50CN¥398.95
MA 200CN¥295.03
MACDBullish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair ValueCN¥75.31
Target PriceCN¥470.67
Upside/Downside19.45%
GradeOvervalued
TypeGrowth
Dividend Yield0.08%
Risk Assessment
Beta0.91
Volatility68.39%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.